Open Journal of Immunology

Volume 2, Issue 1 (March 2012)

ISSN Print: 2162-450X   ISSN Online: 2162-4526

Google-based Impact Factor: 0.91  Citations  

Human B7-H3 binds to Triggering receptor expressed on myeloid cells-like transcript 2 (TLT-2) and enhances T cell responses

HTML  Download Download as PDF (Size: 799KB)  PP. 9-16  
DOI: 10.4236/oji.2012.21002    4,919 Downloads   10,933 Views  Citations

ABSTRACT

The B7 family member B7-H3 is broadly expressed in many tissue and tumor types. B7-H3 expression is induced on some immune cells; however, its immunological function remains controversial, because both immunoenhancing and immunoinhibitory effects have been reported in human and mouse systems. We have previously reported the following: 1) murine B7-H3 specifically bound to Triggering receptor expressed on myeloid cells (TREM)-like transcript 2 (TLT-2, TREML2), a member of the TREM family of receptors; and 2) the B7-H3:TLT-2 pathway up-regulated T cell responses. However, the expression and function of human TLT-2 has not yet been clarified. A recent study found no evidence to support the existence of an interacttion between human B7-H3 and TLT-2. In this study, we demonstrated that human B7-H3 binds to TLT-2 and augments T cell responses. Human and mouse B7-H3Ig chimeric proteins cross-interacted with both human and mouse species of TLT-2-transduced cells. Human TLT-2 was expressed on freshly isolated, peripheral blood B cells and monocytes, and subpopulations of CD4+ and CD8+ T cells. Human TLT-2 expression on T cells did not correlate with na?ve or memory phenotypes and was diminished after culture, despite the presence of mitogenic stimuli. Constitutive TLT-2 expression on monocytes was also down-regulated after culture. Human B7-H3 transfectants augment IL-2 production from TLT-2-transduced T cell hybridomas, and IFN-γ production from peripheral blood CD4+ and CD8+ T cells. The enhanced responses were inhibited by the addition of anti-TLT-2 mAbs, suggesting TLT-2-mediated costimulatory effect. Our results demonstrate the existence of a functional interaction between human B7-H3 and TLT-2, and the restricted expression of TLT-2 on T cells and monocytes.

Share and Cite:

Hashiguchi, M. , Inamochi, Y. , Nagai, S. , Otsuki, N. , Piao, J. , Kobori, H. , Kanno, Y. , Kojima, H. , Kobata, T. and Azuma, M. (2012) Human B7-H3 binds to Triggering receptor expressed on myeloid cells-like transcript 2 (TLT-2) and enhances T cell responses. Open Journal of Immunology, 2, 9-16. doi: 10.4236/oji.2012.21002.

Cited by

[1] Mining of transcriptome identifies CD109 and LRP12 as possible biomarkers and deregulation mechanism of T cell receptor pathway in Acute Myeloid …
Heliyon, 2022
[2] The Role of CD276 in Cancers
2021
[3] Expression of the immune checkpoint B7-H3 in tumor and its soluble form in serum of patients with bone neoplasms
2021
[4] Экспрессия контрольной точки иммунитета B7-H3 в опухоли и ее растворимой формы в сыворотке крови больных новообразованиями костей
2021
[5] B7-H3 in tumors: friend or foe for tumor immunity?
Cancer Chemotherapy and Pharmacology, 2018
[6] influence of irradiated Peripheral Blood Mononuclear cells on Both Ex Vivo Proliferation of human natural Killer cells and change in cellular Property
Frontiers in immunology, 2017
[7] Preferential induction of the T cell auxiliary signaling molecule B7-H3 on synovial monocytes in rheumatoid arthritis
Journal of Biological Chemistry, 2015
[8] VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy
Cancer immunology research, 2014
[9] The role of B7 family molecules in hematologic malignancy
Blood, 2013
[10] Generation and Characterization of Two Novel Monoclonal Antibodies Produced Against Human TLT-2 Molecule
Monoclonal antibodies in immunodiagnosis and immunotherapy, 2013
[11] The role of B7 family molecules in hematological malignancy
2012

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.